Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: A preliminary study

OBJECTIVE: To describe the association of calcitriol treatment with the change in parathyroid hormone (PTH) and biochemical markers of bone disease in infants with metabolic bone disease of prematurity (MBD) and secondary hyperparathyroidism. STUDY DESIGN: This retrospective chart review examined se...

Descripción completa

Detalles Bibliográficos
Autores principales: Rustico, Stacy E., Kelly, Andrea, Monk, Heather M., Calabria, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685017/
https://www.ncbi.nlm.nih.gov/pubmed/29159104
http://dx.doi.org/10.1016/j.jcte.2014.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685017/
https://www.ncbi.nlm.nih.gov/pubmed/29159104
http://dx.doi.org/10.1016/j.jcte.2014.12.001

Ejemplares similares